TRICuspid Intervention in Heart Failure Trial (TRICI-HF)
TRICuspid Intervention in Heart Failure Trial (TRICI-HF-DZHK24)
Sponsor: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
A NA clinical study on Heart Failure Attributable to Severe Tricuspid Regurgitation, this trial is ongoing. The trial is conducted by Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) and has accumulated 12 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2026 — Present [monthly]
Recruiting NA
-
Sep 2025 — Feb 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2022 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Oct 2021 — Apr 2022 [monthly]
Not Yet Recruiting NA
-
Mar 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Heart Center Leipzig - University Hospital
- Heart and Diabetes Center North Rhine-Westphalia
- LMU Klinikum
- University Medical Center Mainz
- University of Leipzig
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bad Krozingen, Germany , Bad Oeynhausen, Germany , Bad Rothenfelde, Germany , Berlin, Germany , Bonn, Germany , Cologne, Germany , Dortmund, Germany , Erfurt, Germany , Essen, Germany , Frankfurt, Germany and 10 more locations